<DOC>
	<DOCNO>NCT02123992</DOCNO>
	<brief_summary>The aim study evaluate safety efficacy Elevate® Apical Posterior Prolapse Repair System repair apical/posterior pelvic organ prolapse control , post-market cohort study .</brief_summary>
	<brief_title>Study Elevate Apical Posterior Prolapse Repair System Compared Native Tissue Repair Pelvic Organ Prolapse</brief_title>
	<detailed_description>The Harmony 522 study terminate due closing Astora Women 's Health business . No entity take responsibility study . The study terminate partial subject enrollment complete therefore primary secondary data analysis perform . The data study reside national data base Astora long access therefore another reason data analysis perform . The national database own managed American Urogynecology Society ( AUGS ) . AUGS access Astora 's data time near future publish result physician active participant registry . Full public disclosure data may occur number year aggregate data study sponsor .</detailed_description>
	<mesh_term>Prolapse</mesh_term>
	<mesh_term>Pelvic Organ Prolapse</mesh_term>
	<criteria>Subject female Subject least 18 year age Subject must document diagnosis posterior posterior apical vaginal prolapse lead edge pelvic organ prolapse beyond hymen . At beyond hymen define POPQ score Bp ≥ 0 ; Bp ≥ 0 C ≥ 1/2 TVL ( multicompartment posterior prolapse include apical compartment ) Subject report bothersome bulge see feel per PFDI20 , question 3 , response 2 high ( i.e. , responses `` somewhat '' , `` moderately '' , `` quite bit '' ) Subject subject 's legally authorized representative willing provide write informed consent Subject willing able comply followup regimen Subject pregnant intend become pregnant study Subject active chronic systemic infection include gynecologic infection , untreated urinary tract infection ( UTI ) tissue necrosis Subject history pelvic organ cancer ( e.g . uterine , ovarian , bladder , cervical ) Subject prior currently undergo radiation , laser therapy , chemotherapy pelvic area Subject take systemic steroid ( within last month ) , immunosuppressive immunomodulatory treatment ( within last 3 month ) Subject systemic connective tissue disease ( e.g . scleroderma , systemic lupus erythematosus ( SLE ) , Marfan 's syndrome , Ehlers Danhlos , collagenosis , polymyositis polymyalgia rheumatica ) Subject chronic systemic pain include pelvic area chronic focal pain involve pelvis Subject uncontrolled diabetes mellitus ( DM ) Subject know neurologic medical condition affect bladder function ( e.g. , multiple sclerosis , spinal cord injury stroke residual neurologic deficit ) Subject seek obliterative vaginal surgery treatment pelvic organ prolapse ( colpocleisis ) Subject able conform modify dorsal lithotomy position Subject currently participate plan participate another device drug study study Subject know sensitivity polypropylene Subject previous prolapse repair mesh target compartment Subject planning undergo concomitant repair use mesh nontarget compartment</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>